ALK-Abello A/S Eulerpool Nyheter

ALK-Abello A/S Aktiens nyheter

ALK-Abello A/S bevakas av många journalister och investerare över hela världen. De senaste ALK-Abello A/S nyheterna samlar vi här.

• 12 december ·

  Yahoo
  ACARIZAX® approved in Europe for treatment of young children
• 27 november ·

  Yahoo
  ALK’s pivotal phase 3 trial in children published in reputable scientific journal
• 19 november ·

  Yahoo
  Alk-Abello AS (AKBLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved Margins
• 18 november ·

  Yahoo
  3 Stocks That May Be Trading At A Discount Of Up To 41.4%
• 15 november ·

  SeekingAlpha
  ALK-Abelló A/S (AKBLF) Q3 2024 Earnings Conference Call Transcript
• 15 november ·

  SeekingAlpha
  ALK-Abelló A/S 2024 Q3 - Results - Earnings Call Presentation
• 14 november ·

  Yahoo
  Nine-month interim report (Q3) 2024 (unaudited)
• 12 november ·

  Yahoo
  ARS Pharmaceuticals announces agreement with ALK to commercialize neffy
• 11 november ·

  Yahoo
  ALK snags EU and Canada rights to anaphylaxis nasal spray Neffy for $145m
• 9 november ·

  Yahoo
  ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)